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1312Objectives: Obesity in the United States is a growing epidemic that results in challenging patients with com-
plicated comorbidities. We sought to compare hospital outcomes of obese patients with those of nonobese
patients undergoing pulmonary lobectomy for cancer.
Methods:We performed a retrospective cohort analysis of obese (body mass index  30 kg/m2) and nonobese
(body mass index<30 kg/m2) patients undergoing pulmonary lobectomy for lung cancer. By using the Nation-
wide Inpatient Sample database from 2002 to 2007, we determined independent risk factors for perioperative
death, discharge to an institutional care facility, and prolonged hospital length of stay (>14 days). Cohorts
were matched on the basis of propensity scores incorporating preoperative patient variables.
Results: We identified 1238 obese patients (3.7%) and 31,983 nonobese patients (96.3%) undergoing lobec-
tomy for cancer. In regard to patient demographics, obese patients were younger (mean age, 64.8 vs 66.7,
P< .001) and predominantly female (59.5% vs 50.0%, P< .001) compared with nonobese patients. After
matching based on propensity scores, except for a greater incidence of pulmonary insufficiency (P ¼ .03)
and pneumonia (P¼ .01) in the obese group, there were no differences in postoperative complications. By con-
trolling for patient demographics, obese patients had higher odds to be discharged to an institutional care facility
(odds ratio, 1.21; P ¼ .02) but not for prolonged hospital length of stay or perioperative death.
Conclusions: Obese patients have an increased risk for postoperative pulmonary complications but not other
morbidity, mortality, or prolonged hospital length of stay after lobectomy for cancer. Obesity should not be con-
sidered a surgical risk factor for pulmonary resection. (J Thorac Cardiovasc Surg 2013;145:1312-8)Earn CME credits at
http://cme.ctsnetjournals.org
Obesity in theUnitedStates has increased froman incidence of
15% in 1980 to more than 35% in 2010, with more than 65%
of US residents currently overweight or obese.1,2 Obesity may
pose risks to surgery that are not present in the nonobese
population. Medical conditions associated with obesity, such
as hypoventilation syndromes, cardiac arrhythmias, wound
healing complications, and proinflammatory states, cause
clinicians to be hesitant to proceed with surgery as a means
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The Journal of Thoracic and Cardiovascular Surincrease in postoperative morbidity in the obese patient after
nonbariatric surgery, although not perioperative or 30-day
mortality.5,6
The impact of obesity on general thoracic surgery out-
comes is unclear. Single institution studies suggest that obe-
sity may not be a risk factor for pulmonary lobectomy and
esophagectomy for postoperative complications and mortal-
ity.7,8Wequeried theHealthcareCost andUtilization Project
Nationwide Inpatient Sample (HCUP-NIS) database and
used a propensity score (PS) matched analysis to compare
perioperative mortality and morbidity rates between
nonobese and obese patients undergoing pulmonary
lobectomy for lung cancer. In addition, we compared the
incidence of discharge to an institutional care facility
(ICF) and rate of prolonged length of stay (PLOS).MATERIALS AND METHODS
Database
This is a retrospective cohort analysis of hospital discharge data for the
years 2002 to 2007, from the HCUP-NIS. The HCUP-NIS is the largest
all-payer inpatient care database in the United States. HCUP-NIS is an
approximate 20% stratification of US hospitals representing 44 states,
1050 hospitals, and approximately 8 million hospital stays.9 This project
was approved by the institutional review board of the University of Califor-
nia, Davis Medical Center.
Patient Selection and Search Criteria
Patients were identified by procedure codes, and preoperative and post-
operative morbidity were identified by disease codes. All procedure andgery c May 2013
Abbreviations and Acronyms
BMI ¼ body mass index
CHF ¼ congestive heart failure
CI ¼ confidence interval
HCUP-NIS ¼ Healthcare Cost and Utilization
Project Nationwide Inpatient Sample
ICD-9-CM ¼ International Classification of
Diseases, 9th edition, Clinical
Modification
ICF ¼ institutional care facility
OR ¼ odds ratio
PLOS ¼ prolonged length of stay
PS ¼ propensity score
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Sdisease codes were based on the International Classification of Diseases,
9th edition, Clinical Modification (ICD-9-CM) Volume 3. The overall
study population included patients who received pulmonary lobectomy
(ICD-9-CM codes 32.40, 32.41, and 32.49) for the primary diagnosis of
lung cancer (ICD-9-CM codes 162.0-162.9, 197.0-197.3). From this popu-
lation, patients were divided into 2 cohorts on the basis of body mass index
(BMI): nonobese (BMI<30 kg/m2) and obese (BMI  30 kg/m2).
Patient and Hospital Demographics and
Perioperative Outcomes
Patient demographics studied included age, sex, race, primary mode of
payment, and preoperative comorbidities. Preoperative comorbidities
measured were diabetes mellitus, hypertension, coronary artery disease,
congestive heart failure (CHF), peripheral vascular disease, chronic
obstructive pulmonary disease, gastroesophageal esophageal reflux dis-
ease, and chronic kidney disease. The hospital demographic measured
was hospital type (ie, rural, urban nonteaching and urban teaching). Perio-
perative outcomes measured included occurrence of PLOS as defined by
hospital stay more than 14 days, discharge disposition (routine to home,
ICF, or death at the time of discharge), and postoperative morbidity. Post-
operative morbidity included cardiac complications, respiratory complica-
tions, nervous system complications, renal complications, gastrointestinal
complications, vascular complications, surgical wound complications, and
other. A list of ICD-9-CM codes for all measured pre- and postoperative
comorbidities is found in Appendix 1. For the majority of the preoperative
comorbidity ICD-9-CM codes analyzed, their listing for a patient discharge
is most likely preprocedure; thus, it is impossible to know definitively on
the basis of the deidentified design of the NIS database.
Statistical Analysis
Differences in the distribution of patient disposition/outcome (routine
[to home], discharged to ICF, or died), patient demographics (including
age, sex, race, primary expected payer, and hospital type), and pre- and
postoperative comorbidities were evaluated using the t test for continuous
variables and chi-square test for proportions. The primary analyses exam-
ine the association between obesity status and likelihood of discharge to an
ICF, mortality, and PLOS. For this purpose, the PS method was used to
obtain matched sets of nonobese patients to each obese patient on the basis
of PS matching. For this study, the PS is the probability of being obese as
a function of preoperative patient variables, and the estimated PS was
obtained using logistic regression.10,11 The PS-matched sets were then
used in logistic regression models to evaluate the likelihood (odds) of dis-
charge to ICF (relative to routine). Likewise, logistic regression was used to
evaluate the odds of dying. For PLOS, which potentially depends on patientThe Journal of Thoracic and Cardisposition/outcome (routine, discharged to ICF, or died), logistic regres-
sion models were considered for data stratified by patient disposition. All
analyses were performed using SAS 9.2 (SAS Institute Inc, Cary, NC).
All P values reported are for 2-sided tests.RESULTS
Patient Demographics
The study cohorts consisted of 1238 obese patients
(3.7%) and 31,983 nonobese patients (96.3%) (Table 1).
From 2002 to 2007, there was a 32.7% increase in the num-
ber of obese patients undergoing lobectomy for lung cancer,
with obese patients accounting for 2.8% of total lobecto-
mies in 2002 to 4.6% in 2007. Obese and nonobese patients
both demonstrated a similar mean age (64.8 vs 66.7 years)
and predominantly white race (85.0% vs 86.5%). A higher
percentage of obese patients were female than nonobese
patients (59.5% vs 50.0%, P<.001). The majority of all
patients had Medicare/Medicaid as the primary expected
payer, with nonobese patients exhibiting a higher predilec-
tion toward Medicare/Medicaid compared with obese
patients (62.9% vs 58.8%, P ¼ .006). A higher number
of nonobese patients had their surgery performed at urban
teaching hospitals (55.2% vs 50.3%, P ¼ .002). Obese
patients had more preoperative comorbidities (Table 1).
Obese patients had higher rates of diabetes mellitus, hyper-
tension, coronary artery disease, CHF, and gastroesopha-
geal esophageal reflux disease (all P  .003).
Perioperative Outcomes
On the basis of the cohort of PS-matched sets, there were
more obese patients (31.0%) than nonobese patients
(26.7%) discharged to an ICF and higher perioperativemor-
tality in the nonobese group compared with the obese cohort
(2% vs 1.2%; Table 2). PLOS was more common among
nonobese patients (8.6%) relative to obese patients (6.4%;
P¼ .01). Therewas no difference in postoperativemorbidity
among obese and nonobese patients except for pulmonary
insufficiency and pneumonia, which were more prevalent
in the obese cohort (9.5% vs 7.7%, P ¼ .03 and 19.7% vs
16.7%, P ¼ .01, respectively; Table 2).Odds of Discharge to an Institutional Care Facility,
Perioperative Mortality, and Prolonged Length of
Stay
On the basis of PS-matched sets, we examined the likeli-
hood (odds) of patients being discharged to an ICF relative
to routine discharge to home among obese and nonobese
patients, adjusted for patient demographics (including age,
sex, race, primary expected payer, and hospital type) and
pre- and postoperative morbidities (Table 3). Obese patients
were more likely to be discharged to an ICF odds ratio [OR],
1.21 (95% confidence interval [CI], 1.03-1.43; P¼ .02). In-
creasing age, female sex, and black race were associated
with increased odds of discharge to an ICF. The odds ofdiovascular Surgery c Volume 145, Number 5 1313
TABLE 1. Patient demographics
Variable
Obese
(n ¼ 1238)
Nonobese
(n ¼ 31,983) P
valueCount % Count %
Age, mean (SD) 64.8 (9.9) 66.7 (10.5) <.001
Sex
Male 501 40.5 15,965 50.0 <.001
Female 737 59.5 15,987 50.0
Race
White 801 85.0 20,604 86.5 .128
Black 76 8.1 1528 6.4
Other 65 6.9 1698 7.1
Type of hospital
Rural 60 4.8 1847 5.8 .002
Urban nonteaching 555 44.8 12,478 39.0
Urban teaching 623 50.3 17,658 55.2
Primary expected
payer
Medicare/Medicaid 727 58.8 20,101 62.9 .006
Private/HMO 467 37.8 10,714 33.5
Self 23 1.9 463 1.4
Other 20 1.6 677 2.1
Preoperative
morbidity
Obese
(n ¼ 1238)
Nonobese
(n ¼ 31,983) P
valueCount % Count %
Diabetes mellitus 31 2.5 233 0.7 <.001
Hypertension 809 65.3 14,305 44.7 <.001
Coronary artery
disease
243 19.6 5084 15.9 .001
CHF 76 6.1 1388 4.3 .003
PVD unspecified 34 2.7 1161 3.6 .101
COPD 488 39.4 12,261 38.3 .442
GERD 223 18.0 4080 12.8 <.001
Chronic kidney
disease
16 1.3 311 1.0 .236
SD, Standard deviation; HMO, Health Maintenance Organization; CHF, congestive
heart failure; PVD, peripheral vascular disease; COPD, chronic obstructive pulmo-
nary disease; GERD, gastroesophageal reflux disease.
TABLE 2. Perioperative/postoperative events (for propensity score
matched sets data)
Variable
Obese
(n ¼ 1238)
Nonobese
(n ¼ 6179) P
valueCount % Count %
Disposition
Routine 839 67.8 4396 71.2 .003
ICF 383 31.0 1650 26.7
Died 15 1.2 124 2.0
Prolonged LOS* 79 6.4 529 8.6 .011
Postoperative morbidity
Acute MI 1 0.1 13 0.2 .338
Atrial fibrillation/
flutter
189 15.3 906 14.7 .585
Other cardiac
complications
56 4.5 285 4.6 .891
Pulmonary embolus 4 0.3 17 0.3 .772
Pulmonary
insufficiency
118 9.5 476 7.7 .031
Pneumonia 244 19.7 1034 16.7 .011
Other respiratory
complications
79 6.4 331 5.4 .150
Stroke 1 0.1 17 0.3 .205
Other nervous system
complications
1 0.1 4 0.1 .843
ARF 26 2.1 125 2.0 .861
UTI 37 3.0 133 2.2 .073
Other renal
complications
11 0.9 61 1.0 .747
GI complications 24 1.9 112 1.8 .763
Venous DVT lower
extremity
1 0.1 10 0.2 .499
Other vascular
complications
1 0.1 6 0.1 .864
Infectious
complications
5 0.4 29 0.5 .756
ICF, Institutional care facility; LOS, length of stay; MI, myocardial infarction; ARF,
acute renal failure; UTI, urinary tract infection; GI, gastrointestinal; DVT, deep
venous thrombosis. *PLOS if more than 14 days.
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nance Organization and self-pay primary expected payer
typewere lower compared withMedicare/Medicaid. Except
for pneumonia and gastrointestinal complications, all other
postoperativemorbidities were significantly associated with
increased odds of discharge to an ICF.
Likewise, on the basis of PS-matched data, we as-
sessed the likelihood of perioperative death among obese
and nonobese patients, adjusted for patient demograph-
ics and pre- and postoperative morbidities (Table 4).
Obesity status was not associated with perioperative
death (OR, 0.63; 95% CI, 0.33-1.18; P ¼ .15). Other
factors predictive of reduced likelihood of perioperative
mortality include decreasing age and urban hospital
(both teaching and nonteaching) relative to rural hospital
(all P  .03). Preoperative CHF was associated with in-
creased odds of death (OR, 1.96; 95% CI, 1.06-3.61;1314 The Journal of Thoracic and Cardiovascular SurP ¼ .03) and preoperative coronary artery disease
(OR, 1.98; 95% CI, 1.22-3.24; P< .01). Only the post-
operative morbidities pulmonary insufficiency and renal
complications were significantly associated with in-
creased odds of death.
Likewise, we examined the likelihood of PLOS between
obese and nonobese groups among patients with routine dis-
position. The models were adjusted for important relevant
confounders as described previously. The results are sum-
marized in Table 5. In the cohort of patients with routine
disposition, the odds of PLOS were not different between
the groups of obese and nonobese patients (OR, 0.79;
95%CI, 0.50-1.22; P¼ .28; Table 5). As expected, all post-
operative morbidities were associated with increased odds
of PLOS (all P<.05), except for other cardiac complica-
tions (P ¼ .43) and gastrointestinal complications
(P ¼ .50). Among preoperative comorbidities, chronicgery c May 2013
TABLE 3. Predictors of discharge to an institutional care facility (for
propensity score matched sets data)
Variable OR 95% CI P value
Obese 1.214 1.033-1.426 .018
Age 1.048 1.039-1.057 <.001
Sex 1.515 1.328-1.729 <.001
Race, black 1.281 1.019-1.61 .034
Race, other 0.815 0.630-1.055 .121
Hospital type, urban nonteaching 0.973 0.730-1.297 .853
Hospital type, urban teaching 0.850 0.640-1.128 .260
Primary expected payer, private/HMO,
Medicare/Medicaid
0.707 0.600-0.833 <.001
Primary expected payer, self 0.451 0.251-0.811 .008
Primary expected payer, other 0.668 0.402-1.110 .120
Preoperative morbidity
Hypertension 0.969 0.845-1.112 .656
Coronary artery disease 1.134 0.967-1.329 .122
CHF 1.698 1.267-2.275 <.001
PVD unspecified 1.051 0.694-1.59 .815
COPD 1.221 1.075-1.387 .002
GERD 1.051 0.895-1.233 .547
Other (diabetes, CKD) 1.573 1.136-2.178 .006
Postoperative morbidity
Atrial fibrillation/flutter 1.292 1.074-1.554 .007
Other cardiac complications* 1.351 1.000-1.825 .050
Pulmonary insufficiency 1.804 1.421-2.289 <.001
Pneumonia 1.151 0.958-1.383 .132
Other respiratory complicationsy 1.451 1.088-1.934 .011
Renal complications
(other, UTI, ARF)
1.885 1.421-2.501 <.001
GI complications 1.453 0.930-2.268 .101
Other complicationsz 2.191 1.180-4.069 .013
OR, Odds ratio; CI, confidence interval; HMO, Health Maintenance Organization;
CHF, congestive heart failure; PVD, peripheral vascular disease; COPD, chronic
obstructive pulmonary disease; GERD, gastroesophageal reflux disease; CKD,
chronic kidney disease; UTI, urinary tract infection; ARF, acute renal failure; GI, gas-
trointestinal. *Includes 56 acute myocardial infarctions. yIncludes 123 pulmonary
emboli. zIncludes stroke, nervous system other, vascular complication other, deep
venous thrombosis lower extremity, and infectious complication.
TABLE 4. Predictors of mortality (for propensity score matched sets
data)
Variable OR 95% CI P value
Obese 0.627 0.333-1.180 .148
Age 1.034 1.004-1.066 .028
Sex 1.041 0.660-1.640 .864
Race, black 1.394 0.656-2.963 .388
Race, other 1.574 0.734-3.372 .244
Hospital type, urban nonteaching 0.408 0.183-0.910 .028
Hospital type, urban teaching 0.296 0.131-0.670 .004
Primary expected payer, private/
HMO, Medicare/Medicaid
0.811 0.426-1.546 .525
Primary expected payer, self 1.443 0.349-5.960 .612
Primary expected payer, other 1.516 0.338-6.800 .587
Preoperative morbidity
Hypertension 0.784 0.495-1.241 .299
Coronary artery disease 1.984 1.215-3.240 .006
CHF 1.958 1.063-3.607 .031
PVD unspecified 1.913 0.634-5.770 .250
COPD 0.953 0.609-1.492 .834
GERD 0.813 0.404-1.637 .562
Other (diabetes, CKD) 0.902 0.335-2.433 .839
Postoperative morbidity
Atrial fibrillation/flutter 1.002 0.580-1.732 .993
Other cardiac complications* 1.843 0.865-3.929 .113
Pulmonary insufficiency 13.087 7.993-21.427 <.001
Pneumonia 1.032 0.608-1.753 .906
Other respiratory
complicationsy
1.632 0.830-3.209 .156
Renal complications
(other, UTI, ARF)
3.688 2.110-6.445 <.001
GI complications 0.344 0.072-1.64 .181
Other complicationsz 2.838 0.959-8.404 .060
OR, Odds ratio; CI, confidence interval; HMO, Health Maintenance Organization;
CHF, congestive heart failure; PVD, peripheral vascular disease; COPD, chronic
obstructive pulmonary disease; GERD, gastroesophageal reflux disease; CKD,
chronic kidney disease; UTI, urinary tract infection; ARF, acute renal failure; GI, gas-
trointestinal. *Includes 56 acute myocardial infarctions. yIncludes 123 pulmonary
emboli. zIncludes stroke, nervous system other, vascular complication other, deep
venous thrombosis lower extremity, and infectious complication.
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Sobstructive pulmonary disease was associated with in-
creased likelihood of PLOS (P<.05).DISCUSSION
Obesity intuitively would seem to be an independent risk
factor for major surgery. Hypoventilation syndromes, cardiac
arrhythmias, wound-healing complications, and proinflamma-
tory states are common in the obese patient populations,3,4 but
other metabolic abnormalities also are prevalent, such as
deficiencies in protein synthesis efficiency and elevated
muscle catabolism in response to trauma.11 In the trauma pop-
ulation, obese patients exhibit a higher risk of mortality and
morbidity compared with nonobese patients.12,13 Although
most nonbariatric general surgical studies examining the
impact of obesity on perioperative outcome demonstrate an
increased risk for morbidity, including atrial fibrillation,
surgical site infection, and embolism, there are few data to
support an increase in mortality.5,6The Journal of Thoracic and CarThe cardiothoracic surgical literature demonstrates
mixed results. Although there are few data to support obe-
sity as an independent risk factor for perioperative mortal-
ity, Zacharias and colleagues14 demonstrated an increased
risk of atrial fibrillation in obese patients undergoing coro-
nary artery bypass grafting. Kuduvalli et al15 found an in-
creased risk of perioperative arrhythmia, sternal wound
infections, and longer hospital stay in obese patients under-
going coronary artery bypass grafting. In regard to general
thoracic surgery, Scipione et al8 retrospectively reviewed
more than 2000 patients undergoing transhiatal esophagec-
tomy, of whom 133 were profoundly obese (BMI  35
kg/m2), and found no difference in mortality, morbidity (ex-
cept recurrent laryngeal nerve injury, which was higher in
the obese group), hospital length of stay, or intensive care
unit stay. For pulmonary resection, Smith et al7 found no
difference in perioperative mortality or morbidity in 127diovascular Surgery c Volume 145, Number 5 1315
TABLE 5. Predictors of prolonged length of stay (for propensity score
matched sets data)
Variable OR 95% CI P value
Obese 0.787 0.509-1.218 .283
Age 0.974 0.957-0.992 .004
Sex 0.891 0.649-1.222 .473
Race, black 1.393 0.848-2.290 .191
Race, other 0.593 0.300-1.170 .132
Hospital type, urban nonteaching 0.973 0.483-1.962 .940
Hospital type, urban teaching 0.799 0.399-1.601 .527
Primary expected payer, private/
HMO, Medicare/Medicaid
0.586 0.407-0.844 .004
Primary expected payer, self 0.415 0.123-1.405 .158
Primary expected payer, other 0.518 0.155-1.732 .286
Preoperative morbidity
Hypertension 0.670 0.487-0.921 .014
Coronary artery disease 0.731 0.471-1.133 .161
Heart failure 1.037 0.475-2.264 .927
PVD unspecified 0.970 0.332-2.837 .956
COPD 1.374 1.003-1.881 .048
GERD 0.613 0.376-1.001 .050
Other (diabetes, CKD) 1.413 0.625-3.193 .407
Postoperative morbidity
Atrial fibrillation/flutter 1.591 1.014-2.497 .044
Other cardiac complications* 1.320 0.663-2.626 .429
Pulmonary insufficiency 3.701 2.375-5.766 <.001
Pneumonia 1.815 1.235-2.666 .002
Other respiratory
complicationsy
1.823 1.043-3.187 .035
Renal complications
(other, UTI, ARF)
1.978 1.055-3.710 .034
GI complications 1.401 0.526-3.726 .500
Other complicationsz 10.007 3.779-26.499 <.001
OR, Odds ratio; CI, confidence interval; HMO, Health Maintenance Organization;
PVD, peripheral vascular disease; COPD, chronic obstructive pulmonary disease;
GERD, gastroesophageal reflux disease; CKD, chronic kidney disease; UTI, urinary
tract infection; ARF, acute renal failure;GI, gastrointestinal. *Includes 56 acute myo-
cardial infarctions. yIncludes 123 pulmonary emboli. zIncludes stroke, nervous sys-
tem other, vascular complication other, deep venous thrombosis lower extremity, and
infectious complication.
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viewing 154 patients undergoing pneumonectomy, Petrella
et al16 found that obese patients (defined as BMI  25 kg/
m2, n ¼ 93) have a 5-fold increase in respiratory
complications.15
Our data, a national retrospective review of perioperative
outcomes of 1238 obese and 31,983 nonobese patients
undergoing lobectomy for cancer, found similar results to
those of previous smaller single institution studies. We found
that despite having fewer preoperative comorbidities and
a higher predilection toward having their surgery performed
at academic teaching hospitals, nonobese patients demon-
strated higher perioperative mortality than obese patients
and a higher incidence of PLOS. We found no difference in
perioperative morbidity, including wound infections and
deep venous thrombosis, but obese patients exhibited a higher
incidence of respiratory complications compared with1316 The Journal of Thoracic and Cardiovascular Surmatched nonobese patients. Contrary to the adult cardiac sur-
gery literature,14,15 obese patients did not have an increase
incidence of atrial fibrillation/flutter compared with
nonobese patients. In our study, obese patients demonstrated
a higher propensity to be discharged to an ICF compared
with nonobese patients. Obesity was in fact an independent
risk factor for discharge to an ICF. This may explain the
decreased incidence of PLOS in the obese population.
There are limitations to our analysis. The results of this
study would suggest an obesity protection paradox; however,
the obese patients may have been a highly selected group.
HCUP-NIS does not provide cancer stage information or pul-
monary function results, such as diffusion capacity for the
lungs for carbon monoxide or forced expiratory volume in
1 second. There may have been stage inequities between
groups, and the obese patientsmay have been selected for op-
timal lung function above recommended guidelines. Also,
during the study period, there was no ICD-9-CM code for
video-assisted thoracoscopic lobectomy used by the data-
base; therefore it would be impossible to determine whether
the obese cohort had a higher incidence of video-assisted
thoracoscopic lobectomy, which has been shown to result in
diminished perioperative complications.17,18 Obesity is
defined as BMI 30 kg/m2 or greater; however, other
reports suggest that BMI may not be the most accurate
measurement of obesity-related perioperative risk.Computed
tomography quantitative measurement of visceral adiposity
may identify at-risk populations independently of BMI.19,20CONCLUSIONS
Despite having more preoperative comorbidities and
a higher predilection to undergoing surgery at nonteaching
hospitals compared with nonobese patients, outside of pul-
monary complications, obese patients do not have an
increased risk for postoperative morbidity, mortality, or
PLOS after lobectomy for cancer. Obese patients undergo-
ing lobectomy for cancer do have an independent increased
odds of being discharged to an ICF rather than to home.
Obesity should not be considered a prohibitive surgical
risk factor for pulmonary resection. Therefore, obese pa-
tients should undergo surgical standard of care therapy for
appropriately stage-specific lung cancer. However, given
the independent increased risk of postoperative pulmonary
insufficiency and pneumonia in obese patients, attention
should be given to aggressive prophylactic respiratory ther-
apy in the perioperative period.References
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5853 Chronic kidney disease
5854 Chronic kidney disease
5855 Chronic kidney disease
5856 Chronic kidney disease
5859 Chronic kidney disease
Postoperative Morbidity
Cardiac complications
9971 Cardiac complications
4100 Acute MI
4101 Acute MI
4102 Acute MI
4103 Acute MI
4104 Acute MI
4105 Acute MI
4106 Acute MI
4107 Acute MI
4108 Acute MI
4109 Acute MI
42731 Atrial fibrillation (Afib/flutter)
42732 Atrial flutter (Afib/flutter)
Respiratory Complications
9973 Respiratory complications (respiratory complications other)
99739 Other respiratory complications (other)
41510 PE and infarction (pulmonary embolus)
41511 Iatrogenic PE and infarction (pulmonary embolus)
51881 Acute respiratory failure (pulmonary insufficiency)
51882 Other pulmonary insufficiency (pulmonary insufficiency)
51884 Acute on chronic respiratory failure (pulmonary insufficiency)
5184 Acute edema of lung, unspecified (pulmonary insufficiency)
5185 Pulmonary insufficiency after trauma and surgery (pulmonary
insufficiency)
485 Pneumonia
486 Pneumonia
4820 Pneumonia
4821 Pneumonia
4822 Pneumonia
48230 Pneumonia
48231 Pneumonia
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APPENDIX 1. International Classification of Diseases, 9th edition,Clinical Modification codes
Preoperative Morbidity
25001 Diabetes mellitus
25002 Diabetes mellitus
25003 Diabetes mellitus
4010 Hypertension
4011 Hypertension
4019 Hypertension
41400 Coronary artery disease
41401 Coronary artery disease
4280 Heart failure
4289 Heart failure
4439 Peripheral vascular disease, unspecified
496 COPD (COPD/emphysema)
4928 Emphysema (COPD/emphysema)
53081 Esophageal reflux
5851 Chronic kidney disease
5852 Chronic kidney disease
(Continued)
48232 Pneumonia
48239 Pneumonia
48240 Pneumonia
48241 Pneumonia
48242 Pneumonia
48249 Pneumonia
48281 Pneumonia
48282 Pneumonia
48283 Pneumonia
48289 Pneumonia
4829 Pneumonia
5180 Atelectasis
Nervous System Complications
99700 Nervous system complications unspecified (nervous system
other)
99701 Central nervous system complication (other)
99702 Iatrogenic cerebrovascular infarction or hemorrhage (stroke)
99709 Other nervous system complications (other)
(Continued)
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APPENDIX 1. Continued
Renal Complications
9975 Urinary complications (renal complications other)
5845 ARF
5846 ARF
5847 ARF
5849 ARF
5990 UTI
GI Complications
9974 Digestive system complications (GI complications other)
5601 Paralytic ileus
Vascular Complications
9972 Peripheral vascular complications (vascular complications
other)
45340 Venous DVT lower extremity
45341 Venous DVT lower extremity
45342 Venous DVT lower extremity
Other Infectious Complications
99851 Infected postoperative seroma
99859 Other postoperative infection
Wound
99883 Nonhealing surgical wound
Other
9989 Complications affecting other specified body systems, not
elsewhere classified
COPD, Chronic obstructive pulmonary disease; MI, myocardial infarction; Afib,
atrial fibrillation; PE, pulmonary embolism; ARF, acute renal failure; UTI, urinary
tract infection; GI, gastrointestinal; DVT, deep vein thrombosis.
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